A California woman who allegedly developed kidney failure after taking Invokana (generic: canagliflozin) has filed a product liability lawsuit seeking punitive damages from drugmaker Janssen Pharmaceuticals.
Free Confidential Lawsuit Evaluation: If you or a loved one was injured by Invokana side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the problem?
March 31, 2016 – According to the complaint, which was filed in the U.S. District Court for the Central District of California, plaintiff was prescribed Invokana to treat the symptoms of her type 2 diabetes. The woman claims that after taking the medication as directed, she was hospitalized in April 2015 and then again in May 2015 for acute kidney injury and acute kidney failure, respectively. Had Janssen adequately warned about the risk of these conditions, plaintiff alleges she would have never taken Invokana, as there are safer alternatives available.
In May 2015, the U.S. Food & Drug Administration (FDA) issued a warning which stated that Invokana and other diabetes drugs from the SGLT2 inhibitor class had been linked to adverse health complications including diabetic ketoacidosis (DKA), a potentially fatal condition that occurs when the blood becomes too acidic.
The same month FDA issued its warning, the Institute for Safe Medication Practices (ISMP) released its QuarterWatch publication, in which the agency expressed concern about the potential health risks associated with Invokana. ISMP reported that in the first year the drug was on the U.S. market, it was linked to at least 450 adverse event reports, many of which cited kidney impairment, kidney stones and/or kidney failure.
Plaintiff alleges that although the Invokana label mentions the kidneys, it does so in a very general manner, stating that a “possible side effect” is “kidney problems.” This warning doesn’t adequately convey the dangers or address the actual risk of kidney failure, according to the lawsuit.
Like others who have filed complaints against Janssen, plaintiff in this case blames the company for failing to adequately research Invokana to determine its safety, and for aggressively promoting the drug as a safe treatment for diabetes while simultaneously downplaying its risks.
She further alleges that Invokana is significantly more dangerous than the ordinary consumer would expect, and that Janssen knew or should have known that the drug’s warning label was incorrect and misleading. Plaintiff asserts counts of strict liability, design defect, failure to warn, negligence, breach of warranties, fraud, misrepresentation, fraudulent concealment, negligent misrepresentation and violation of the Fair Business Practices Act of 1975, and seeks both compensatory and punitive damages in excess of $75,000.
Do I Have an Invokana Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Invokana lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
Free Confidential Case Evaluation: Again, if you were harmed by Invokana, you should contact our law firm immediately. You may be entitled to a settlement by filing a lawsuit and our lawyers can help.